Plain-English translation of NCT05970133 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether robotic-assisted surgery offers better recovery and outcomes than traditional laparoscopic (camera-assisted) surgery for patients with left-sided colon cancer. Both approaches use small incisions and a camera to guide the surgery, but robotic surgery uses mechanical arms controlled by the surgeon. The key innovation both methods are exploring is removing the cancerous portion of your colon through your rectum rather than making a separate belly incision — which may reduce pain, infection risk, and recovery time.
Standard laparoscopic colon cancer surgery requires an extra abdominal incision to remove the diseased tissue, which increases pain, infection risk, and can delay follow-up chemotherapy. This trial exists to see whether robotic technology can make the newer approach (extracting tissue through the rectum) safer and easier for surgeons to perform, while maintaining the same cancer-fighting effectiveness.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either robotic-assisted laparoscopic surgery or traditional laparoscopic surgery to remove the cancerous section of your colon. Both procedures use small incisions and involve extracting the tissue through your rectum rather than through a separate belly incision. After surgery, you would be followed up to assess your pain levels, recovery speed, infection risk, and long-term cancer outcomes. The trial will enroll 300 patients across the National Taiwan University Hospital.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Taiwan